Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
US9598402B2 · kind B2 · utility
1Cited by
1References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2012 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Aug 20, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a process for treating or preventing a viral infection in a subject, wherein the viral infection is from a flavivirus selected from the group consisting of Hepatitis C Virus (genotypes 1-7) and Japanese Encephalitis Virus. The process includes administering to the subject a therapeutically effective amount of at least one compound represented by the formula: (Formula (I))
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.